Please login to the form below
MedAvante
This page shows the latest MedAvante news and features for those working in and with pharma, biotech and healthcare.
Latest appointments
-
J&J’s clinical research neuroscience director joins MedAvante
Global clinical data services company MedAvante has appointed Dr Michael Ropacki as vice president of research and development. ... He also brings extensive experience in psychiatry, neurology and dermatology, making him an ideal addition to MedAvante's
More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- NHS App to revolutionise digital health and care with major digital updates by 2023
- Eli Lilly to supply US government with 150,000 additional doses of bebtelovimab
- Innovative Health Initiative launches first two calls for proposals to tackle ‘biggest’ health research challenges
- New Omicron sub-variants cause COVID-19 cases to rise in the UK
- Dermavant publishes positive phase 3 data for treatment of plaque psoriasis
- EMA grants Bavarian Nordic access to PRIME scheme for RSV vaccine candidate
- Early communications in Pharma: How effective pre-approval comms delivers launch success
- Create Health Showreel
- AstraZeneca acquires TeneoTwo in a deal worth up to $1.27bn
- Cancer Research UK urges government to realise ‘science superpower’ ambitions as new report highlights ‘huge’ economic value
- Novartis UK launches first health-tech investor partnership to address cardiovascular care
- UK government invests £175m to ‘supercharge’ clinical research
- A creative awakening – how pharma is bringing innovation to the patient journey
- European Commission approves potential new treatment for Pompe disease
- Sanofi Global Health unveils new nonprofit Impact brand
- J&J looks ahead at potential flu therapy after approval of its COVID-19 vaccine
- New Omicron sub-variants cause COVID-19 cases to rise in the UK
- Novartis UK launches first health-tech investor partnership to address cardiovascular care
PMHub
Havas Life Medicom
We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by...
Latest intelligence
- Early communications in Pharma: How effective pre-approval comms delivers launch success
- What communications are required for a successful launch...
- Our Top 5 Pharma Picks From Cannes Lions
- Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
- The Evolving Role of the Sales Rep
- The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
